Jordan S. Pober

Person

Guilford, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Enhanced targeting platform
- Patent number 12,162,953
- Issue date Dec 10, 2024
- Yale University
- W. Mark Saltzman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for identifying modulators of tumor necrosis factor receptors
- Patent number 9,081,017
- Issue date Jul 14, 2015
- Cambridge Enterprise Limited
- John Bradley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of interleukin-11 to prevent immune-mediated cytotoxicity
- Patent number 6,953,777
- Issue date Oct 11, 2005
- Genetics Indtitute LLC
- James Keith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense modulation of LFA-3
- Patent number 6,001,651
- Issue date Dec 14, 1999
- ISIS Pharmaceuticals Inc.
- C. Frank Bennett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunodeficient animal model for studying T cell-mediated immune
- Patent number 5,602,305
- Issue date Feb 11, 1997
- Yale University
- Jordan S. Pober
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHOD OF INHIBITING EXACERBATIONS OF T CELL-MEDIATED ALLOGRAFT VAS...
- Publication number 20240024470
- Publication date Jan 25, 2024
- Alexion Pharmaceuticals, Inc.
- Jordan S. Pober
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENHANCED TARGETING PLATFORM
- Publication number 20210206879
- Publication date Jul 8, 2021
- Yale University
- W. Mark Saltzman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
A METHOD OF INHIBITING EXACERBATIONS OF T CELL-MEDIATED ALLOGRAFT V...
- Publication number 20180311345
- Publication date Nov 1, 2018
- Alexion Pharmaceuticals, Inc.
- Jordan Pober
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR MODIFYING ENDOTHELIAL CELLS
- Publication number 20180066253
- Publication date Mar 8, 2018
- Jordan POBER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Use of Interleukin-11 to Prevent Immune-Mediated Cytotoxicity
- Publication number 20090191147
- Publication date Jul 30, 2009
- Genetics Institute, LLC
- James Keith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Selective Modulation of Tumour Necrosis Factor Receptors in Therapy
- Publication number 20080176796
- Publication date Jul 24, 2008
- John Bradley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Vascularized human skin equivalent
- Publication number 20070207125
- Publication date Sep 6, 2007
- Alfred L.M. Bothwell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of interleukin-11 to prevent immune-mediated cytotoxicity
- Publication number 20060062760
- Publication date Mar 23, 2006
- Genetics Institute Inc.
- James Keith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Production and use of microvessels in fibronectin-containing gel
- Publication number 20040072342
- Publication date Apr 15, 2004
- Alfred L.M. Bothwell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of interleukin-11 to prevent immune-mediated cytotoxicity
- Publication number 20010051600
- Publication date Dec 13, 2001
- James Keith
- Y10 - TECHNICAL SUBJECTS COVERED BY FORMER USPC

Jordan S. Pober

Person

Patents Grantslast 30 patents

Enhanced targeting platform

Methods for identifying modulators of tumor necrosis factor receptors

Use of interleukin-11 to prevent immune-mediated cytotoxicity

Antisense modulation of LFA-3

Immunodeficient animal model for studying T cell-mediated immune

Patents Applicationslast 30 patents

METHOD OF INHIBITING EXACERBATIONS OF T CELL-MEDIATED ALLOGRAFT VAS...

ENHANCED TARGETING PLATFORM

A METHOD OF INHIBITING EXACERBATIONS OF T CELL-MEDIATED ALLOGRAFT V...

METHODS AND COMPOSITIONS FOR MODIFYING ENDOTHELIAL CELLS

Use of Interleukin-11 to Prevent Immune-Mediated Cytotoxicity

Selective Modulation of Tumour Necrosis Factor Receptors in Therapy

Vascularized human skin equivalent

Use of interleukin-11 to prevent immune-mediated cytotoxicity

Production and use of microvessels in fibronectin-containing gel

Use of interleukin-11 to prevent immune-mediated cytotoxicity